The Bill and Melinda Gates Foundation, known for concentrating on vaccines and AIDS in its charitable work, has added Ecolab and Monsanto to its portfolio. Monsanto is the world largest biotechnology company dealing in genetically modified organisms.
Health equity in economic and trade policies
Developing countries should be aware of the implications of the WTO dispute
settlement reports on US – Gambling and Mexico – Telecommunications as they continue participating in the WTO negotiations. The findings in the reports have set precedents on the interpretation of various GATS articles and concepts, including: necessity tests; Article XIV on General Exception; Article IV on Increasing Participation of Developing Countries; and scheduling
guidelines.
This publication, on negotiations about trade in services indicates ways that human rights advocates can get involved to ensure their governments do not sign agreements that could have harmful human rights effects. Access to essential services, including water, education and health care are on the table as representatives at the WTO push for closure to trade talks in the coming months. Advocates must act now to ensure these agreements include full consideration of the potential human rights impacts of new policies. This Action Alert sets out actions and strategies for human rights advocates concerned about the issue.
The Government of Kenya (GoK) in partnership with United Nations Population Fund (UNFPA) at the sidelines of the 60th Session of the UN Commission of Women in New York launched the report on the ‘Assessment of the UNFPA Campaign to End Preventable Maternal and New-born Mortality in support of the Campaign for Accelerated Reduction of Maternal Mortality in Africa’ The report captures the important strides the country has made to significantly address disparities in advancing maternal and new-born health at all levels, as part GoK's commitment to address inequalities, as a key principle of Agenda 2030, to ensure that no one is left behind. This video records the event.
This study provides the first detailed economy-wide analysis of the likely gender effects of economic partnership agreements (EPAs) based on the goods tariff liberalisation schedules agreed by Tanzania, Mozambique and Jamaica. The study found that the employment and production effects of trade liberalisation on women will depend on the extent to which women are employed in the sectors sensitive to import competition, but most importantly, their ability to relocate to an expanding sector of production. It predicts that, under an EPA, women’s employment is likely to be minimally affected in Jamaica, Mozambique and Tanzania. Findings suggest that the consumption effect of trade may be regressive: imports, such as washing machines in Mozambique or gas cookers in Tanzania, will most likely benefit the wealthier, as they are not consumed by poorer households. For example, increasing availability of household appliances could reduce the workload of women with access to electricity, but only 7% of Mozambican households have access and an indirect effect could be a drop in demand for domestic workers, most of whom are women. The loss of government revenue from tariff removal constitutes the most immediate and significant impact, estimated at 2% of revenue, with too little time to compensate for lost revenue. The study urges that further monitoring of the implementation of trade liberalisation is required from a gender perspective. The gender-aware framework and analytical approach developed could be used to examine other EPAs and other trade agreements.
Civil society and humanitarian groups slammed the new head of the World Health Organisation (WHO), on the sidelines of a meeting here, after she appeared to favour the interests of pharmaceutical giants over the plight of the sick and the poor in the developing world.
Malaysia's Attorney-General Tan Sri Abdul Gani has publicly stated his country's stand "that generic drugs should not be restricted in any manner," as generics are cheaper than patented medicines. He made this statement before the UN Committee on the Rights of the Child (CRC), whose session concluded in Geneva last week. He was speaking in response to pointed questions from the Committee?s Chair, Jacob E. Doek, who asked Malaysian governmental representatives how they can ensure that trade agreements do not affect provision of generic medicines, particularly for the treatment of HIV/AIDS.
The generic industry is in trouble again, and the issue is now becoming a major non-tariff barrier against developing countries like India. Two large drug consignments of generic medicines were seized in Netherlands by its customs authorities recently. The drugs, while in transit to Peru, were held at Rotterdam port because they infringed patents in EU. Sources said that recently many essential drugs have been held at European ports on way to Africa or Latin America from India by EU customs for intellectual property infringement or by labelling them 'counterfeits'. India is a source of affordable life saving medicines for many African and developing countries, and companies use the established trading route passing through EU ports for supplying essential medicines to millions across the world, potentially jeopardising the lives of those needing drugs in those countries.
The WHO Director General Dr. Margaret Chan, has sent a letter to Thailand's Health Minister expressing regret for the embarrassment caused to his government by remarks she was reported to have made in Bangkok that were critical of the compulsory licenses granted by the government for three medicines. The letter follows the deep offence that Dr. Chan's comments had caused the government and particularly the Minister of Public Health. Dr. Chan's reported comments had also caused outrage among international health NGOs and grassroots health movements worldwide, especially groups representing people living with HIV-AIDS. More than 400 groups and individuals have sent her a protest letter asking her to change her views.
While China's relationship to Africa is much examined, knowledge and analysis of India's role in Africa has until now been limited but, as a significant global player, India's growing interactions with various African countries call for detailed analysis of the Asian giant's influence and its relations with the African continent. In this book, which enables readers to compare India to China and other 'rising powers' in Africa, expert African, Indian and western commentators draw on a collection of accessibly written case studies to explore inter-related areas including trade, investment, development aid, civil society relations, security and geopolitics.
